BVF »

Cidara Therapeutics shares owned by BVF

Quarter-by-quarter ownership of Cidara Therapeutics shares owned by BVF from 13F filings

Historical chart of BVF investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by BVF

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.1M 343k 11.94

More positions owned by BVF

Moonlake Immunotherapeutics Class A Ord (MLTX)
Revolution Medicines (RVMD)
Kymera Therapeutics (KYMR)
Ionis Pharmaceuticals (IONS)
Mirum Pharmaceuticals (MIRM)
Gh Research Ordinary Shares (GHRS)
Protagonist Therapeutics (PTGX)
Cullinan Oncology (CGEM)
Olema Pharmaceuticals (OLMA)
Structure Therapeutics Sponsored Ads (GPCR)
Xoma Corp Del Com New (XOMA)
Kura Oncology (KURA)
4d Molecular Therapeutics In (FDMT)
Axsome Therapeutics (AXSM)
Cg Oncology (CGON)

View all positions for BVF

Top funds holding Cidara Therapeutics

Monashee Investment Management
BVF
Vanguard Group
Checkpoint Capital
Renaissance Technologies
Alethea Capital Management
5AM Venture Management
BlackRock
Geode Capital Management
Schonfeld Strategic Advisors
State Street Corporation
Us Bancorp
Russell Investments
Tower Research Capital
Manchester Capital Management

View all funds holding Cidara Therapeutics